Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis

Clin Infect Dis. 2019 Feb 15;68(5):860-864. doi: 10.1093/cid/ciy573.


Despite the promise of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP), PrEP remains underutilized, often due to clinician factors. Academic or public health detailing is a process by which university and/or government groups employ the marketing practices of pharmaceutical companies to improve clinical practice. We describe the novel application of detailing to increase PrEP prescribing and related care in New York City and New England. Detailing can play a crucial role in PrEP implementation.

Keywords: HIV prevention; PrEP; academic detailing; public health detailing.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / therapeutic use*
  • Drug Prescriptions*
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • Humans
  • New England / epidemiology
  • New York City / epidemiology
  • Pre-Exposure Prophylaxis / methods*
  • Public Health*
  • Sexual and Gender Minorities


  • Anti-HIV Agents